GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » CH Biotech R&D Co Ltd (TPE:6534) » Definitions » Cash from Discontinued Operating Activities

CH Biotech R&D Co (TPE:6534) Cash from Discontinued Operating Activities : NT$0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is CH Biotech R&D Co Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

CH Biotech R&D Co's Cash from Discontinued Operating Activities for the three months ended in Mar. 2025 was NT$0 Mil. It means CH Biotech R&D Co received NT$0 Mil from discontinued investing activities. CH Biotech R&D Co's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0 Mil.


CH Biotech R&D Co Cash from Discontinued Operating Activities Historical Data

The historical data trend for CH Biotech R&D Co's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CH Biotech R&D Co Cash from Discontinued Operating Activities Chart

CH Biotech R&D Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash from Discontinued Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CH Biotech R&D Co Quarterly Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CH Biotech R&D Co Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CH Biotech R&D Co Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of CH Biotech R&D Co's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


CH Biotech R&D Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » CH Biotech R&D Co Ltd (TPE:6534) » Definitions » Cash from Discontinued Operating Activities
Traded in Other Exchanges
N/A
Address
No. 89, Wenxian Road, Nantou County, Nantou, TWN, 540001
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.

CH Biotech R&D Co Headlines

No Headlines